Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. VINGE ADVISES DUSTIN AND ALTOR IN CONNECTION WITH THE LISTING ON NASDAQ STOCKHOLM
Mandate

VINGE ADVISES DUSTIN AND ALTOR IN CONNECTION WITH THE LISTING ON NASDAQ STOCKHOLM

February 17, 2015

Vinge advises Dustin Group AB (publ) and Altor in connection with Dustin’s listing on Nasdaq Stockholm.

Dustin is a leading online based reseller of IT products and services in the Nordics. Dustin offers a wide product and service range to businesses, public organisations and consumers, primarily through its online platform. The Swedish language prospectus was published on 2 February 2015 and the first day of trading was 13 February 2015. The offering price has been set at SEK 50 per share, corresponding to a market value of Dustin of approximately SEK 3,809 million.
Vinge’s team primarily consisted of Peter Bäärnhielm, David Andersson, Sabina Börjesson, Amanda Knutsson and Tora Hansjons.

Vinge företräder Dustin och Altor i samband med börsnoteringen på Nasdaq Stockholm

Related

Vinge advises Stendörren in connection with issuance of green capital securities

 Vinge has advised Stendörren Fastigheter AB in connection with its issuance of green capital securities in an amount of SEK 400 million (within a framework of SEK 800 million).
May 07, 2026

Vinge represents Cinven in connection with the acquisition of Ongoing Warehouse

 Vinge has represented the international private equity firm Cinven in connection with its acquisition of Ongoing Warehouse.
May 06, 2026

Vinge advises Fazer in connection with its acquisition of Aroma

 Fazer has entered into an agreement to acquire Konfektyrfabriken Aroma AB, a Swedish confectionery manufacturer known for its classic candy products such as Geléhallon, Hallonbåtar, Röda Hjärtan and Gräddkola. The acquisition strengthens Fazer's position in the Swedish confectionery market, particularly within pick & mix, packed candy, and seasonal products. The acquisition is subject to customary regulatory approvals.
May 06, 2026